FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer

Rigshospitalet

Status: Completed

Conditions: Lung Cancer, Nonsmall Cell; Small Cell Lung Cancer

Treatments: Device: FLT-PET

Study type: Interventional

Funder types: Other

Identifiers

NCT02995889

308_14

Details and patient eligibility

About

This study investigates the feasibility of FLT-PET to improve the diagnosis of relapse in patients with irradiated lung cancer in comparison with FDG-PET/CT.

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• history with lung cancer, small cell or non-small cell
• radiotherapy of lung cancer ended within the last 24 months
• radiotherapy might be normofractionated or stereotactic
• current suspicion of relapse
• written and oral consent

Exclusion criteria

• communication difficulties
• pregnancy or lactation

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

64 participants in 1 patient group

FLT-PET

Experimental group

Treatment:

Device: FLT-PET